170 related articles for article (PubMed ID: 32659199)
1. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
Oliviero A; de Castro F; Coperchini F; Chiovato L; Rotondi M
Neuroscientist; 2021 Jun; 27(3):214-221. PubMed ID: 32659199
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
3. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
[TBL] [Abstract][Full Text] [Related]
4. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19).
Yazdanpanah N; Saghazadeh A; Rezaei N
Rev Neurosci; 2020 Oct; 31(7):691-701. PubMed ID: 32776905
[TBL] [Abstract][Full Text] [Related]
5. [Loss of smell, a preliminary indicator of COVID-19].
Waizel-Haiat S; Waizel-Bucay J
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
[TBL] [Abstract][Full Text] [Related]
6. Does COVID-19 cause permanent damage to olfactory and gustatory function?
Paolo G
Med Hypotheses; 2020 Oct; 143():110086. PubMed ID: 32721795
[TBL] [Abstract][Full Text] [Related]
7. Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19.
Fantozzi PJ; Pampena E; Di Vanna D; Pellegrino E; Corbi D; Mammucari S; Alessi F; Pampena R; Bertazzoni G; Minisola S; Mastroianni CM; Polimeni A; Romeo U; Villa A
Am J Otolaryngol; 2020; 41(6):102721. PubMed ID: 32977063
[TBL] [Abstract][Full Text] [Related]
8. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
Desai M; Oppenheimer J
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
[TBL] [Abstract][Full Text] [Related]
9. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement.
Baig AM
ACS Chem Neurosci; 2020 May; 11(9):1204-1205. PubMed ID: 32343122
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection.
Galluzzi F; Rossi V; Bosetti C; Garavello W
Neuroepidemiology; 2021; 55(2):154-161. PubMed ID: 33794531
[TBL] [Abstract][Full Text] [Related]
11. Olfactory and rhinological evaluations in SARS-CoV-2 patients complaining of olfactory loss.
Ottaviano G; Carecchio M; Scarpa B; Marchese-Ragona R
Rhinology; 2020 Aug; 58(4):400-401. PubMed ID: 32338254
[TBL] [Abstract][Full Text] [Related]
12. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
13. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.
Zhang N; Zhao YD; Wang XM
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7497-7505. PubMed ID: 32706090
[TBL] [Abstract][Full Text] [Related]
14. What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409036
[TBL] [Abstract][Full Text] [Related]
15. Loss of smell in COVID-19 patients: a critical review with emphasis on the use of olfactory tests.
Marchese-Ragona R; Restivo DA; De Corso E; Vianello A; Nicolai P; Ottaviano G
Acta Otorhinolaryngol Ital; 2020 Aug; 40(4):241-247. PubMed ID: 33100334
[TBL] [Abstract][Full Text] [Related]
16. [Olfactory dysfunction and COVID-19 - current state of the problem].
Karapetyan LS; Svistushkin VM
Vestn Otorinolaringol; 2020; 85(6):100-104. PubMed ID: 33474926
[TBL] [Abstract][Full Text] [Related]
17. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
18. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
Lechner M; Chandrasekharan D; Jumani K; Liu J; Gane S; Lund VJ; Philpott C; Jayaraj S
Rhinology; 2020 Aug; 58(4):394-399. PubMed ID: 32386285
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody profiles assessment in individuals with persistent olfactory impairment following SARS-CoV-2 infection.
Fiorelli D; Francavilla B; Velletrani G; Maurantonio S; Passali FM; Bernardini S; Di Girolamo S; Nuccetelli M
Int Immunopharmacol; 2024 Mar; 129():111599. PubMed ID: 38330796
[TBL] [Abstract][Full Text] [Related]
20. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
Bereczki D; Stang R; Böjti P; Kovács T
Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
